HCP Inc (HCP) 37.00 $HCP Robbins Arroyo LLP: HCP, Inc.

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
HCP Inc (HCP) 37.00 $HCP

Robbins Arroyo LLP: HCP, Inc. (HCP) Misled Shareholders According to a Recently Filed Class Action
BusinessWire - Tue Jul 12, 6:23PM CDT
Shareholder rights law firm Robbins Arroyo LLP announces that a class action complaint was filed against HCP, Inc. (NYSE: HCP) in the U.S. District Court for the Central District of California. The complaint is brought on behalf of all purchasers of HCP securities between March 30, 2015 and February 8, 2016, for alleged violations of the Securities Exchange Act of 1934 by HCP's officers and directors. HCP is an independent hybrid real estate investment trust.
HCP: 37.00 (-0.03)

HCP Names Michael D. McKee as New Interim President, CEO
Zacks Equity Research - Zacks Investment Research - Tue Jul 12, 7:45AM CDT
HCP, Inc. (HCP) announced the appointment of Michael D. McKee, its Executive Chairman, to play the additional roles of interim President and CEO.
HCP: 37.00 (-0.03), APLE: 19.57 (+0.01), WPC: 70.35 (+0.41), COR: 87.32 (-0.06)

DEADLINE TODAY: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against HCP, Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Jul 11, 11:41AM CDT
IRVINE, CA / ACCESSWIRE / July 11, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against HCP, Inc. ("HCP" or the "Company" (NYSE: HCP). Investors who purchased or otherwise acquired shares between March 30, 2015 and February 8, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 11, 2016 lead plaintiff motion deadline.
HCP: 37.00 (-0.03)

HCP 72 HOUR DEADLINE ALERT: APPROXIMATELY 72 HOURS REMAIN; FORMER LOUISIANA ATTORNEY GENERAL AND KAHN SWICK & FOTI, LLC REMIND INVESTORS of Deadline in Class Action Lawsuit Against HCP, Inc. - HCP
GlobeNewswire - Fri Jul 08, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with large financial interests that they have only until July 11, 2016 to file lead plaintiff applications in a securities class action lawsuit against HCP, Inc. (NYSE:HCP). Investor losses must relate to purchases of the Company's securities between March 30, 2015 and February 8, 2016. This action is pending in the United States District Court for the Northern District of Ohio.
HCP: 37.00 (-0.03)

3-DAY DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against HCP Inc. And Reminds Investors With Losses To Contact The Firm
ACCESSWIRE - Fri Jul 08, 4:20PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 8, 2016 / Lundin Law PC announces that a class action lawsuit has been filed against HCP Inc. ("HCP" or the "Company" (NYSE: HCP) concerning possible violations of federal securities laws between March 30, 2015 and February 8, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016 lead plaintiff motion deadline.
HCP: 37.00 (-0.03)

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Shareholders of HCP, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2016 - HCP
PR Newswire - Fri Jul 08, 10:08AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
HCP: 37.00 (-0.03)

INVESTOR NOTICE: Goldberg Law PC Announces Securities Class Action Lawsuit Against HCP, Inc. and Encourages Investors With Losses to Contact the Firm
BusinessWire - Thu Jul 07, 7:04PM CDT
Goldberg Law PC (www.Goldberglawpc.com) announces that a class action lawsuit has been filed against HCP, Inc. ("HCP" or the "Company" (NYSE: HCP). Investors who purchased or otherwise acquired shares between March 30, 2015 and February 8, 2016 (the "Class Period", are encouraged to contact the firm in advance of the July 11, 2016 lead plaintiff motion deadline.
HCP: 37.00 (-0.03)

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against HCP, Inc. and Certain Officers - HCP
GlobeNewswire - Thu Jul 07, 6:05PM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against HCP, Inc. ("HCP" or the "Company" (NYSE:HCP), and certain of the Company's officers. The class action, filed in United States District Court, Central District of California, and docketed under 16-cv-04981, is on behalf of a class consisting of all persons other than Defendants who purchased or acquired HCP securities between March 30, 2015 and February 8, 2016, both dates inclusive (the "Class Period", seeking to recover damages caused by Defendants' violations of the federal securities laws and to pursue remedies under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 (the "Exchange Act" and Rule 10b-5 promulgated thereunder.
HCP: 37.00 (-0.03)

Will Ventas Gain from $1.5B Life-Sciences Real Estate Deal?
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 3:19PM CDT
Ventas Inc. (VTR) signed a deal to acquire significantly all of the life science and medical real estate assets of Wexford, marking its foray into the thriving university-affiliated life science real estate business.
HCP: 37.00 (-0.03), BX: 24.89 (+0.32), OHI: 33.11 (+0.39), VTR: 71.99 (+0.13)

HCP to Report Second Quarter 2016 Financial Results and Host Conference Call/Webcast
PR Newswire - Thu Jul 07, 3:15PM CDT
HCP (NYSE:HCP) is scheduled to report its second quarter 2016 financial results on Tuesday, August 9, 2016, before the open of trading on the New York Stock Exchange. HCP will also host a conference call and webcast at 9:00 a.m. Pacific Time (12:00 p.m. Eastern Time) that same day in order to review its financial performance and operating results for the quarter ended June 30, 2016.
HCP: 37.00 (-0.03)

HCP Set to Possibly Rebound After Yesterday's Selloff of 2.00%
Comtex SmarTrend(R) - Thu Jul 07, 1:27PM CDT
HCP (NYSE:HCP) traded in a range yesterday that spanned from a low of $34.56 to a high of $35.50. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $35.12 on volume of 1.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
HCP: 37.00 (-0.03)

Watch for HCP to Potentially Rebound After Falling 2.00% Yesterday
Comtex SmarTrend(R) - Thu Jul 07, 1:26PM CDT
HCP (NYSE:HCP) traded in a range yesterday that spanned from a low of $34.56 to a high of $35.50. Yesterday, the shares fell 2.0%, which took the trading range below the 3-day low of $35.12 on volume of 1.6 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
HCP: 37.00 (-0.03)

GPM Reminds Investors of the July 11 Deadline in the Class Action Lawsuit against HCP, Inc.
BusinessWire - Wed Jul 06, 9:30AM CDT
Glancy Prongay & Murray LLP ("GPM" reminds investors of the July 11, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class" of investors who purchased HCP, Inc. ("HCP" or the "Company" (NYSE: HCP) securities between March 30, 2015 and February 8, 2016, inclusive (the "Class Period". HCP investors have until July 11, 2016 to file a lead plaintiff motion.
HCP: 37.00 (-0.03)

DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action against HCP, Inc. (HCP) and Lead Plaintiff Deadline: July 11, 2016
ACCESSWIRE - Wed Jul 06, 9:07AM CDT
NEW YORK, NY / ACCESSWIRE / July 6, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against HCP, Inc. ("HCP" or "the Company" (NYSE: HCP). The class action has been filed on behalf of a class consisting of all persons or entities who purchased HCP from March 30, 2015 through February 8, 2016, inclusive (the "Class Period".
HCP: 37.00 (-0.03)

July 11 Deadline Alert: Law Offices of Howard G. Smith Reminds Investors of the Upcoming Deadline in the Class Action Lawsuit Against HCP, Inc.
BusinessWire - Fri Jul 01, 10:57AM CDT
Law Offices of Howard G. Smith reminds investors of the upcoming July 11, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class" of investors who purchased HCP, Inc. ("HCP" or the "Company" (NYSE: HCP) securities between March 30, 2015 and February 8, 2016, inclusive (the "Class Period". HCP investors have until July 11, 2016 to file a lead plaintiff motion.
HCP: 37.00 (-0.03)

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of HCP, Inc. of Class Action Lawsuit and a Lead Plaintiff Deadline of July 11, 2016 - HCP
GlobeNewswire - Wed Jun 29, 3:29PM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
HCP: 37.00 (-0.03)

Hagens Berman Reminds HCP, Inc. (NYSE: HCP) Investors of July 11, 2016 Lead Plaintiff Deadline in Securities Class Action Concerning Overstated Asset Values
GlobeNewswire - Mon Jun 27, 3:00AM CDT
Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, reminds HCP, Inc. (NYSE:HCP) investors of July 11, 2016 Lead Plaintiff deadline in the securities class action filed in the U.S. District Court for the Northern District of Ohio.
HCP: 37.00 (-0.03)

FINAL NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against HCP, Inc. And Encourages Investors With Losses To Contact The Firm
ACCESSWIRE - Sat Jun 25, 4:45PM CDT
IRVINE, CA / ACCESSWIRE / June 25, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against HCP, Inc. ("HCP" or the "Company" (NYSE: HCP). Investors who purchased or otherwise acquired shares between March 30, 2015 and February 8, 2016, inclusive (the "Class Period", are encouraged to contact the Firm prior to the July 11, 2016, lead plaintiff motion deadline.
HCP: 37.00 (-0.03)

DEADLINE APPROACHING: Lundin Law PC Announces Securities Class Action Lawsuit Against HCP, Inc. And Reminds Investors With Losses To Contact The Firm
ACCESSWIRE - Fri Jun 24, 4:32PM CDT
LOS ANGELES, CA / ACCESSWIRE / June 24, 2016 / Lundin Law PC announces a class action lawsuit has been filed against HCP, Inc. ("HCP" or the "Company" (NYSE: HCP) concerning possible violations of federal securities laws between March 30, 2015 and February 8, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the July 11, 2016, lead plaintiff motion deadline.
HCP: 37.00 (-0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Global Child Tests Purpose Travel's Expanding Media Reach

Updated Category News Views 45

Celebrity travel programming usually melts into the wallpaper, but Global Child is trying to make the scenery answer for itself. Its new season of Global Child “Travel & Purpose” puts Andrea Bocelli in Tuscany, Isabela Merced in Peru and John Malkovich in Croatia, while tying each destination to a broader local-good mission. That is a more thoughtful pitch than...

Continue Reading
DataBeyond Puts AI Sorting Before a Waste Mountain

Updated Category News Views 191

Trash is a lousy place to look for technological glamour, which is precisely why DataBeyond's COP31 appearance deserves a sober look. On November 19 in Antalya, Türkiye, the Hangzhou-based equipment provider used a China Pavilion event to lay out its case for AI, optical sensing and robots in resource recovery. That is not a magic-green headline. It is a practical...

Continue Reading
PettiChat’s Digital Pet Twin Has Real Consumer Pull

Updated Category News Views 410

A Collar Gadget Is Chasing the Empty-House Problem Leave a dog or cat alone for a few hours and plenty of owners turn into amateur detectives. Did the cat eat? Has the dog been pacing? Why was that one weird noise caught on the home camera? Seattle startup PettiChat is trying to turn that itch into a product category with PettiLive!, a screen-based version of a pet that...

Continue Reading
CARsgen's CT1182 Data Opens a Careful New CAR-T Test

Updated Category News Views 126

Six very sick lymphoma patients are not a victory lap, but they can still make the whole cell-therapy field sit up straighter. CARsgen has disclosed first clinical results for CT1182, an in vivo CAR-T candidate built on its CARvivo platform, and the early package is plainly more interesting than the usual preclinical chest-thumping. The company reported three complete...

Continue Reading
UAE Ties Diplomacy, Media and AI Into a Shared Signal

Updated Category News Views 128

Influence is getting harder to measure, and easier to squander, which is why the message from Ajman deserves more than a polite nod. At the 2026 Ajman Media Forum, THE SIGNAL, Foreign Affairs Undersecretary Omar Obaid Alhesan Alshamsi made the UAE’s position plain: diplomacy and media are no longer separate lanes. Both operate on words, context, trust and the difficult...

Continue Reading
FASTEN Data Offers an Early Look at Ladera Closure

Updated Category News Views 137

Femoral access may be the unglamorous part of a valve procedure, but it is where an otherwise tidy case can turn ugly in a hurry. That makes Ladera Medical's full FASTEN data worth a careful look. The company reported results in 55 patients undergoing transfemoral TAVR/TAVI, and the numbers presented at London Valves 2026 suggest its large-bore closure system may address...

Continue Reading
PHONO's 150 MW RE+ Win Tests Its U.S. Solar Staying Power

Updated Category News Views 534

A trade-show order book is not cash in the bank, but 150 MW is still a number worth circling in red. PHONO used RE+ 2026 in Las Vegas, held November 17 through 19, to celebrate 20 years in business, parade its solar and storage lineup, and announce new U.S. orders. In a solar market that has become touchier about provenance, compliance and delivered economics, the company...

Continue Reading
EyePoint Lawsuit Puts DURAVYU Claims Under a Microscope

Updated Category News Views 50

Nothing makes biotech investors reach for the aspirin faster than a lawsuit centered on whether a drug worked as advertised. EyePoint, Inc. is facing a proposed federal securities class action alleging that the company overstated the effectiveness of DURAVYU and, by extension, its clinical, regulatory, and commercial prospects. That is a serious allegation, but it remains...

Continue Reading
Isar’s Nova Scotia Pad Build Gives MAXQ a Real Test

Updated Category News Views 666

Concrete work is where space ambition stops being a brochure. Isar Aerospace has taken operational responsibility for its dedicated launch infrastructure at Spaceport Nova Scotia, and construction is beginning on the Canadian launch pad it will use. For Maritime Launch Services, this is the sort of update that deserves more than the usual starry-eyed applause. A Site...

Continue Reading
Anthropic's Leveraged ETFs Arrive After Wild Debut

Updated Category News Views 731

Nothing says a feverish new listing quite like leveraged products lining up before the opening-week confetti has settled. Anthropic priced its IPO at $83 on November 18, raised roughly $81.3 billion, then opened Nasdaq trading at $111.50 on November 19. That is an enormous gap between IPO price and first trade, and it tells investors the obvious thing: plenty of appetite...

Continue Reading

Top 5 Most Recently Viewed Articles

Luca Mining Welcomes New VP to Boost Corporate Development

Updated Category News Views 123

Luca Mining Corp. Strengthens Leadership Team Luca Mining Corp. (TSXV: LUCA) (OTCQX: LUCMF) is thrilled to announce a strategic addition to its team with the appointment of Mr. Adam Melnyk as Vice President of Corporate Development. This move is set to elevate the company’s business development initiatives and drive growth as it aims to expand its operations in the...

Continue Reading
Sapiens Powers Insurance Innovation at Global Client Conference

Updated Category News Views 149

Sapiens Hosts Global Client Conference to Transform Insurance This event unites insurance leaders to exchange ideas for growth, adaptability, and impactful business strategies. Sapiens International Corporation (NASDAQ: SPNS) recently held its annual International Client Conference, gathering insurance professionals, prospects, and partners for three days of insightful...

Continue Reading
Elon Musk's Rising Influence in Trump's Circles on Social Media

Updated Category News Views 174

Elon Musk's Transformation into a Political Influencer Elon Musk, renowned for his groundbreaking ventures, has recently emerged as a key advocate for former President Donald Trump. Through his platform X, formerly known as Twitter, Musk is significantly amplifying conservative viewpoints. A Shift in Political Engagement Musk’s political activity has noticed a marked...

Continue Reading
Enphase Energy's Earnings: A Potential Turnaround Amid Setbacks

Updated Category News Views 82

Enphase Energy's Earnings Anticipation Enphase Energy Inc. (NASDAQ: ENPH) is preparing to announce its third-quarter earnings. The anticipated earnings per share stand at 77 cents, with expected revenue reaching approximately $391.98 million. Despite these expectations, investor sentiment appears to be less than optimistic. This solar energy company has faced significant...

Continue Reading
Is the 'Sell America 2.0' Trend Resurfacing in the Market?

Updated Category News Views 120

Market Update: Examining Leadership Shifts As global yields rise, US megacaps face pressure as investors revisit the 'Sell America' strategy. Notably, the S&P 500 has recently broken important technical levels, with noticeable fatigue in tech, media, and telecom leadership. On the other hand, diversification appears to be paying off, as small caps, foreign equities, and...

Continue Reading